期刊文献+

母乳低聚糖组成及其对益生菌的增殖作用 被引量:1

Oligosaccharide Composition of Human Breast Milk and Its Effect on Promoting the Proliferation of Probiotics
下载PDF
导出
摘要 研究混合母乳中复杂的母乳低聚糖(human milk oligosaccharides,HMOs)组成及含量,选择双歧杆菌Bb-12、发酵乳杆菌CECT57162种益生菌,研究HMOs 2’-岩藻糖(2’-fucosyllactose,2’-FL)对2种益生菌的增殖作用。结果表明:2个混合样本的HMOs含量分别为10.613、5.093 g/L,差异很大,说明不同母乳来源的HMOs受诸多因素影响,但含量范围一般为5~15 g/L;2’-FL对发酵乳杆菌CECT5716和双歧杆菌Bb-12均有一定的增殖效果,说明益生菌可以利用HMOs进行生长和增殖。 The composition and contents of oligosaccharides in two mixed samples of human breast milk were determined and the effect of the human milk oligosaccharides(HMOs)2’-fucosyllactose(2’-FL)on the proliferation of two probiotic strains,Bifidobacterium Bb-12 and Lactobacillus fermentum CECT5716 was evaluated in this study.The results showed that the HMOs contents of the two mixed samples were 10.613 and 5.093 g/L respectively.This significant difference indicated that HMOs contents in breast milk from different mothers are affected by many factors,generally ranging between 5 and 15 g/L.2’-FL promoted the growth of both priobiotics,indicating that the probiotics could utilize HMOs for growth and proliferation.
作者 揭良 苏米亚 贾宏信 陈文亮 齐晓彦 JIE Liang;SU Miya;JIA Hongxin;CHEN Wenliang;QI Xiaoyan(Shanghai Engineering Research Center of Dairy Biotechnology,State Key Laboratory of Dairy Biotechnology,Dairy Research Institute,Bright Dairy and Food Co.Ltd.,Shanghai 200436,China)
出处 《乳业科学与技术》 2021年第1期13-17,共5页 JOURNAL OF DAIRY SCIENCE AND TECHNOLOGY
基金 “十三五”国家重点研发计划重点专项(2018YFC1604205) 上海市科学技术委员会科研计划项目(17391901100) 上海乳业生物工程技术研究中心项目(19DZ2281400)。
关键词 母乳 母乳低聚糖 益生菌增殖 双歧杆菌 发酵乳杆菌 human milk human milk oligosaccharides proliferation of probiotics Bifidobacterium Lactobacillus fermentum
  • 相关文献

参考文献3

二级参考文献81

  • 1《特殊医学用途配方食品通则征求意见稿》,2012,中华人民共和国卫生部.
  • 2殷继永,黄建,霍军生.特殊膳食用食品膳食补充剂全球概况[N].中国食品报,2009-02-13:8.
  • 3American Academy of Pediatrics, Committee on Nutrition (美国儿科学会营养委员会). Reimbursement for foods for special dietary rose [J]. American Academy of Pediatrics, 2003,111 ( 5 ) : 1117- 1119.
  • 4Hata Y, Kakajima K. Studies of relationship betweenintake of fructooligosaccharides and abdominal symptoms:estimation of the-maximumnon-effective dose and 50% laxative effect dose [J]. Geriatr Med,1985 (23) :817.
  • 5Tokunaga T, Nakada Y, Tashiro Y, Hirayama M, Hidaka H. Effects of fructooligosaccharides ( FOS ) intake on the intestinal microflora and defecation in healthy volunteers [J]. Bifidus Flores, Fructuset Semina, 1993, 6 : 143.
  • 6Ramakrishna B S, Mathan, V I. Colonic dysfunction inacute diarrhoea: The role of luminal short chain fatty acids [J]. Gut 1993, 34:1215.
  • 7Bowling T E, Raimundo A H, Silk D B. Colonicsecretory effect in responseto enteral feeding in man [J]. Gut 1993, 34 (Suppl. 1 ) :33.
  • 8Younes H, Garleb K A, Behr,S. Fermentable fibers or oligosac- charides reduced urinarynitrogen excretion by increasing urea disposal in the ratcecum [ J]. Nutr,1995, 125:1010.
  • 9Bourquin L D, Bennink M R, Rozeboom K A, Wolf B. Fructooligosaccharides (FOS) enhance cecal andcolonic development of neonatal pigs [J]. FASEB J,1997, 11 :A601.
  • 10Breuer R I, Bjio S K, Christ M L, Bean J, Vemia A P, Paoluzi P, DiPaolo M C, Caprilli R. Rectalirrigation with short-chain fatty acids for distal ulcerativecolitis (preliminary report) [ J ]. Dig Dis Sci,1991, 36:185.

共引文献42

同被引文献6

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部